lintuzumab-gelonin conjugate (Hum-195/rGel)
/ Targa Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 19, 2013
Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies
(clinicaltrials.gov)
- P1 | N=28 | Completed | Sponsor: M.D. Anderson Cancer Center | N=36 ➔ 28
Enrollment change • Acute Myelogenous Leukemia • Anemia • Chronic Myelomonocytic Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Myeloproliferative Neoplasm • Oncology • CD33
February 19, 2013
Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies
(clinicaltrials.gov)
- P1 | N=28 | Completed | Sponsor: M.D. Anderson Cancer Center | Active, not recruiting ➔ Completed
Trial completion • Acute Myelogenous Leukemia • Anemia • Chronic Myelomonocytic Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Myeloproliferative Neoplasm • Oncology • CD33
1 to 2
Of
2
Go to page
1